Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Madhumita Shrotri, Maria Krutikov, Tom Palmer, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1529-1538
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 585-594
Open Access | Times Cited: 2900
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis
Caifang Zheng, Weihao Shao, Xiaorui Chen, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 252-260
Open Access | Times Cited: 577
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 533
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 326
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1370-1378
Open Access | Times Cited: 317
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 311
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Jia Wei, Nicole Stoesser, Philippa C. Matthews, et al.
Nature Microbiology (2021) Vol. 6, Iss. 9, pp. 1140-1149
Open Access | Times Cited: 310
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
Heather Whitaker, Ruby S. M. Tsang, Rachel Byford, et al.
Journal of Infection (2022) Vol. 84, Iss. 5, pp. 675-683
Open Access | Times Cited: 156
Hospitalisation among vaccine breakthrough COVID-19 infections
Prerak Juthani, Akash Gupta, Kelly Borges, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1485-1486
Open Access | Times Cited: 151
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 149
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
Wing Ying Au, Peter Pak‐Hang Cheung
BMJ (2022), pp. e069989-e069989
Open Access | Times Cited: 124
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
Eurosurveillance (2021) Vol. 26, Iss. 28
Open Access | Times Cited: 116
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 81
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina
Soledad González, Santiago Olszevicki, Martín R. Salazar, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101126-101126
Open Access | Times Cited: 78
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
Chia Siang Kow, Syed Shahzad Hasan
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1075-1090
Open Access | Times Cited: 75
Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
Clara Mazagatos, Susana Monge, Carmen Olmedo, et al.
Eurosurveillance (2021) Vol. 26, Iss. 24
Open Access | Times Cited: 74
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
А. И. Тухватулин, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, et al.
The Lancet Regional Health - Europe (2021) Vol. 11, pp. 100241-100241
Open Access | Times Cited: 64
Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
Kadhim Hayawi, Sakib Shahriar, Mohamed Adel Serhani, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1305-1305
Open Access | Times Cited: 58
Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 23-23
Open Access | Times Cited: 56
Dynamics of antibody response to CoronaVac vaccine
Marcela Helena Gambim Fonseca, Tamiris de Fátima Goebel de Souza, Fernanda Montenegro de Carvalho Araújo, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2139-2148
Open Access | Times Cited: 54
The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers’ unvaccinated household members
Jussipekka Salo, Milla Hägg, Mika Kortelainen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 5, pp. e347-e355
Open Access | Times Cited: 46
Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada
Matthew J. Oliver, Doneal Thomas, Shabnam Balamchi, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 4, pp. 839-849
Open Access | Times Cited: 44
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top